Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib Donna M. Hepper, MD, Peggy Wu, MD, Milan J. Anadkat, MD Journal of the American Academy of Dermatology Volume 64, Issue 5, Pages 996-998 (May 2011) DOI: 10.1016/j.jaad.2009.08.024 Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 A and B, Patient at presentation, with scalp erythema, pustules, and alopecia. Journal of the American Academy of Dermatology 2011 64, 996-998DOI: (10.1016/j.jaad.2009.08.024) Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Punch biopsy specimens showing an increased number of telogen and catagen hairs with perifollicular chronic inflammation and perifollicular fibrosis consistent with a scarring alopecia. (Original magnifications: A, ×40; B, ×100.) Journal of the American Academy of Dermatology 2011 64, 996-998DOI: (10.1016/j.jaad.2009.08.024) Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions